Showing results (11-20 of 18) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
American Journal of Physiology. Renal Physiology|August 4, 2006
Erythropoietin and the cardiorenal syndrome: cellular mechanisms on the cardiorenal connectorsKim E Jie, Marianne C Verhaar, Maarten-Jan M Cramer, et al.Plos One|June 17, 2015
Relation between Red Cell Distribution Width and Fibroblast Growth Factor 23 Cleaving in Patients with Chronic Kidney Disease and Heart FailureFenna van Breda, Mireille E Emans, Karien van der Putten, et al.Plos One|September 8, 2012
Short-term erythropoietin treatment does not substantially modulate monocyte transcriptomes of patients with combined heart and renal failureKim E Jie, Karien van der Putten, Sebastiaan Wesseling, et al.Journal of Cardiac Failure|August 3, 2011
Determinants of red cell distribution width (RDW) in cardiorenal patients: RDW is not related to erythropoietin resistanceMireille E Emans, Karien van der Putten, Karlijn L van Rooijen, et al.Journal of Nephrology|April 13, 2010
Erythropoietin treatment in patients with combined heart and renal failure: objectives and design of the EPOCARES studyKarien van der Putten, Kim E Jie, Mireille E Emans, et al.Journal of the American Heart Association|August 20, 2019
Epoetin Beta and C-Terminal Fibroblast Growth Factor 23 in Patients With Chronic Heart Failure and Chronic Kidney DiseaseMichele F Eisenga, Mireille E Emans, Karien van der Putten, et al.BMC Cardiovascular Disorders|September 20, 2012
Atherosclerotic renal artery stenosis is prevalent in cardiorenal patients but not associated with left ventricular function and myocardial fibrosis as assessed by cardiac magnetic resonance imagingMireille E Emans, Karien van der Putten, Birgitta K Velthuis, et al.The Journal of Vascular Access|March 16, 2017
Improvement of radiocephalic fistula maturation: rationale and design of the Liposomal Prednisolone to Improve Hemodialysis Fistula Maturation (LIPMAT) study - a randomized controlled trialBram M Voorzaat, Jan van Schaik, Koen E A van der Bogt, et al.Pageof 2